Gastrointestinal Endoscopic Device Market Size, Share, Growth, and Industry Analysis, Types (Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Hemostatis Devices, Capsule Endoscopy, Biopsy Devices, GI Videoscopes), Applications (Hospitals, Diagnostic Centers, Others), and Regional Insights and Forecast to 2035

Gastrointestinal Endoscopic Device Market Size

Global Gastrointestinal Endoscopic Device Market size was USD 231.89 Million in 2025 and is projected to touch USD 233.70 Million in 2026, reach USD 235.52 Million in 2027, and grow to USD 250.63 Million by 2035, exhibiting a CAGR of 0.78% during the forecast period from 2026 to 2035. The market continues to witness stable demand due to increasing gastrointestinal disease diagnosis, growing preference for minimally invasive procedures, and rising awareness regarding colorectal cancer screening. Nearly 43% of gastrointestinal patients now undergo endoscopic procedures for faster diagnosis and treatment planning.

The US Gastrointestinal Endoscopic Device Market is growing steadily because healthcare providers continue investing in advanced imaging technologies and minimally invasive treatment systems. Nearly 52% of hospitals in the country are upgrading gastrointestinal diagnostic equipment to improve procedure accuracy and patient care quality. Demand for capsule endoscopy and GI videoscope systems has increased by approximately 24%, while colorectal screening procedures continue rising due to stronger preventive healthcare awareness.

Key Findings

• Market Size: Valued at USD 231.89 Million in 2025, projected to touch USD 233.70 Million in 2026, reach USD 235.52 Million in 2027, and USD 250.63 Million by 2035 at a CAGR of 0.78%.
• Growth Drivers: Nearly 56% patients prefer minimally invasive diagnosis, 31% procedures increased, and 27% hospitals upgraded imaging systems.
• Trends: Around 36% systems use high-definition imaging, 23% facilities prefer flexible videoscopes, and 19% adopt capsule endoscopy technologies.
• Key Players: Medtronic, Boston Scientific, Stryker, Johnson & Johnson, Fujinon & more.
• Regional Insights: North America holds 36% share, Europe 29%, Asia-Pacific 24%, and Middle East & Africa 11% supported by diagnostic expansion.
• Challenges: Nearly 24% providers face sterilization concerns, 18% report maintenance costs, and 16% require advanced technical training.
• Industry Impact: About 55% demand comes from hospitals, while 46% procedures rely on advanced GI imaging systems for diagnosis.
• Recent Developments: Around 21% imaging accuracy improved, 19% workflow efficiency increased, and 18% capsule imaging clarity enhanced.

The Gastrointestinal Endoscopic Device Market continues to benefit from increasing digestive disease awareness, expanding colorectal screening programs, and rising healthcare focus on early diagnosis. Manufacturers are improving imaging quality, patient comfort, and infection prevention technologies to support safer and more efficient gastrointestinal procedures. Growing investment in flexible endoscopy systems and digital integration tools is also supporting long-term healthcare modernization across hospitals and diagnostic centers.

Gastrointestinal Endoscopic Device Market Trends

The Gastrointestinal Endoscopic Device Market is experiencing stable growth due to increasing gastrointestinal disease cases, rising awareness regarding early diagnosis, and growing adoption of minimally invasive procedures. Nearly 61% of healthcare professionals now prefer endoscopic procedures because they reduce recovery time and lower surgical complications. Around 47% of gastrointestinal diagnostic procedures are performed using advanced endoscopic systems due to improved imaging and patient comfort. Demand for GI videoscopes has increased by approximately 29% because hospitals and diagnostic centers are focusing on accurate visualization and faster diagnosis. Capsule endoscopy devices are also gaining popularity, with adoption increasing by nearly 22% among patients requiring non-invasive gastrointestinal examination. Healthcare facilities continue upgrading endoscopic equipment, and approximately 38% of hospitals are investing in high-definition imaging systems to improve diagnostic precision. The growing elderly population is another major factor supporting the Gastrointestinal Endoscopic Device Market, as nearly 34% of gastrointestinal procedures are performed on aging patients with digestive disorders. Demand for disposable endoscopic accessories has increased by around 19% because infection prevention remains a major concern in healthcare environments. Hemostasis devices continue to witness strong demand due to increasing gastrointestinal bleeding cases, while biopsy devices are becoming more common in cancer detection procedures. Technological improvements in flexible endoscopy systems and digital imaging are also supporting the long-term expansion of the Gastrointestinal Endoscopic Device Market across hospitals and diagnostic centers.

Gastrointestinal Endoscopic Device Market Dynamics

OPPORTUNITY

"Growth in minimally invasive gastrointestinal procedures"

The increasing preference for minimally invasive diagnosis and treatment is creating strong opportunities in the Gastrointestinal Endoscopic Device Market. Nearly 56% of patients now prefer non-surgical gastrointestinal procedures because they involve faster recovery and reduced hospital stays. Demand for advanced imaging endoscopy systems has increased by approximately 27%, while capsule endoscopy usage has grown by around 21% due to improved patient comfort and early disease detection capabilities.

DRIVERS

"Rising prevalence of gastrointestinal disorders"

Increasing digestive disease cases are strongly driving the Gastrointestinal Endoscopic Device Market. Nearly 43% of gastrointestinal patients require endoscopic diagnosis for conditions related to ulcers, bleeding, and colorectal disorders. Colonoscopy and endoscopy procedures have increased by approximately 31% because healthcare providers are emphasizing early disease detection. Around 36% of healthcare facilities are also upgrading diagnostic imaging systems to improve accuracy and patient management efficiency.

RESTRAINTS

"High equipment and maintenance costs"

The Gastrointestinal Endoscopic Device Market faces restraints related to the high cost of advanced endoscopic systems and maintenance requirements. Nearly 29% of small healthcare facilities delay equipment upgrades because of budget limitations. Repair and sterilization expenses for GI videoscopes have increased by approximately 18%, affecting operating costs for healthcare providers. Around 16% of diagnostic centers also report difficulties related to staff training and technical handling of advanced endoscopic systems.

CHALLENGE

"Infection control and equipment reprocessing concerns"

The Gastrointestinal Endoscopic Device Market continues to face challenges related to infection prevention and equipment sterilization. Nearly 24% of healthcare professionals consider endoscope reprocessing procedures time-consuming and operationally demanding. Concerns regarding cross-contamination have increased by approximately 19%, encouraging hospitals to invest in disposable accessories and advanced cleaning systems. Regulatory compliance requirements for endoscopic device sterilization are also creating operational pressure for healthcare facilities and manufacturers.

Segmentation Analysis

The Global Gastrointestinal Endoscopic Device Market size was USD 231.89 Million in 2025 and is projected to touch USD 233.70 Million in 2026, reach USD 235.52 Million in 2027, and grow to USD 250.63 Million by 2035, exhibiting a CAGR of 0.78% during the forecast period from 2026 to 2035. The market is supported by rising gastrointestinal disease prevalence, increasing use of minimally invasive procedures, and growing demand for accurate diagnostic imaging systems. Healthcare facilities are focusing on improving early disease detection and patient safety, which continues to support steady demand for advanced endoscopic devices across hospitals and diagnostic centers.

By Type

Endoscopic Retrograde Cholangiopancreatography Devices (ERCP)

ERCP devices continue to maintain strong demand because they are widely used in pancreatic and bile duct examinations. Nearly 28% of advanced gastrointestinal procedures involve ERCP systems for diagnostic and therapeutic applications. Hospitals increasingly prefer ERCP devices because they help reduce surgical intervention requirements and improve patient recovery management during complex digestive disorder treatment.

ERCP Devices segment accounted for approximately USD 49.08 Million in 2026, representing nearly 21% of the total Gastrointestinal Endoscopic Device Market share. This segment is projected to grow at a CAGR of 0.9% from 2026 to 2035 due to rising pancreatic disorder cases and increasing preference for minimally invasive treatment procedures.

Hemostatis Devices

Hemostatis devices are increasingly used in gastrointestinal bleeding management and emergency treatment procedures. Nearly 24% of gastrointestinal intervention procedures now involve advanced hemostasis systems because of their effectiveness in controlling internal bleeding. Demand for these devices has increased by approximately 17% due to growing awareness regarding rapid gastrointestinal emergency response.

Hemostatis Devices segment reached nearly USD 42.07 Million in 2026, accounting for approximately 18% of the overall Gastrointestinal Endoscopic Device Market share. The segment is expected to grow at a CAGR of 0.7% during the forecast period from 2026 to 2035 due to increasing gastrointestinal bleeding cases and rising emergency endoscopy procedures.

Capsule Endoscopy

Capsule endoscopy devices are gaining popularity because they provide non-invasive gastrointestinal imaging and improve patient comfort during diagnostic procedures. Nearly 22% of patients now prefer capsule-based gastrointestinal examination due to reduced discomfort compared to traditional endoscopy methods. Adoption has also increased by approximately 19% among diagnostic centers focused on small intestine evaluation.

Capsule Endoscopy segment accounted for approximately USD 39.73 Million in 2026, representing nearly 17% of the total market share. This segment is projected to grow at a CAGR of 1.1% from 2026 to 2035 due to rising patient preference for non-invasive diagnosis and growing awareness regarding early gastrointestinal disease detection.

Biopsy Devices

Biopsy devices remain important in gastrointestinal cancer detection and tissue sampling procedures. Nearly 33% of gastrointestinal diagnostic procedures now involve biopsy collection for laboratory examination and disease confirmation. Hospitals are increasingly using advanced biopsy systems because they improve tissue sample accuracy and support faster pathology evaluation.

Biopsy Devices segment reached nearly USD 44.40 Million in 2026, accounting for approximately 19% of the Gastrointestinal Endoscopic Device Market share. The segment is expected to grow at a CAGR of 0.8% during the forecast period from 2026 to 2035 due to rising cancer screening procedures and increased gastrointestinal disease diagnosis.

GI Videoscopes

GI videoscopes dominate the Gastrointestinal Endoscopic Device Market because healthcare providers increasingly rely on high-definition imaging systems for accurate gastrointestinal diagnosis. Nearly 46% of hospitals now prefer advanced GI videoscope systems with digital imaging capabilities. Demand for flexible videoscope systems has increased by approximately 26% due to improved patient comfort and enhanced visualization during diagnostic procedures.

GI Videoscopes segment accounted for approximately USD 58.43 Million in 2026, representing nearly 25% of the overall market share. This segment is projected to grow at a CAGR of 0.9% from 2026 to 2035 due to increasing demand for high-resolution imaging systems and rising gastrointestinal diagnostic procedure volumes.

By Application

Hospitals

Hospitals remain the leading application segment in the Gastrointestinal Endoscopic Device Market because they perform a large number of diagnostic and therapeutic gastrointestinal procedures. Nearly 62% of advanced endoscopic examinations are conducted in hospitals due to availability of skilled professionals and advanced imaging infrastructure. Healthcare facilities are increasingly investing in upgraded GI endoscopy systems to improve patient care efficiency and disease diagnosis accuracy.

Hospitals segment accounted for approximately USD 128.54 Million in 2026, representing nearly 55% of the total market share. This segment is projected to grow at a CAGR of 0.9% from 2026 to 2035, supported by increasing gastrointestinal procedure volumes and rising healthcare infrastructure modernization.

Diagnostic Centers

Diagnostic centers are witnessing growing demand for gastrointestinal endoscopic devices because outpatient diagnostic procedures are increasing steadily. Nearly 31% of gastrointestinal examinations are now performed in specialized diagnostic centers due to faster appointment availability and lower procedure waiting time. High-definition imaging systems are becoming increasingly common in private diagnostic facilities focused on accurate disease detection.

Diagnostic Centers segment reached nearly USD 72.45 Million in 2026, accounting for approximately 31% of the overall Gastrointestinal Endoscopic Device Market share. The segment is expected to grow at a CAGR of 0.8% during the forecast period from 2026 to 2035 due to rising outpatient diagnostic demand and increasing investment in imaging technologies.

Others

Other healthcare facilities including ambulatory surgical centers and specialty clinics continue contributing to the Gastrointestinal Endoscopic Device Market because minimally invasive procedures are becoming more accessible outside large hospitals. Nearly 14% of gastrointestinal procedures are now conducted in specialty healthcare centers focused on outpatient treatment and rapid patient care services.

Others segment accounted for approximately USD 32.71 Million in 2026, representing nearly 14% of the total market share. This segment is projected to grow at a CAGR of 0.6% from 2026 to 2035 due to increasing expansion of specialty healthcare services and rising preference for outpatient gastrointestinal procedures.

Gastrointestinal Endoscopic Device Market Regional Outlook

The Global Gastrointestinal Endoscopic Device Market size was USD 231.89 Million in 2025 and is projected to touch USD 233.70 Million in 2026, reach USD 235.52 Million in 2027, and grow to USD 250.63 Million by 2035, exhibiting a CAGR of 0.78% during the forecast period from 2026 to 2035. The market is steadily expanding because healthcare providers are increasingly focusing on minimally invasive gastrointestinal diagnosis and early disease detection. Rising digestive disorder cases, growing cancer screening awareness, and increasing use of advanced imaging systems are supporting consistent demand for gastrointestinal endoscopic devices across hospitals and diagnostic centers worldwide.

North America

North America remains the leading region in the Gastrointestinal Endoscopic Device Market because healthcare providers strongly focus on advanced diagnostic procedures and early gastrointestinal disease detection. Nearly 58% of hospitals in the region now use high-definition GI videoscopes to improve diagnostic precision. Colonoscopy and endoscopy procedure volumes have increased by approximately 27% due to rising colorectal screening awareness. Hospitals are also increasing investments in minimally invasive gastrointestinal treatment systems.

North America held approximately 36% of the global Gastrointestinal Endoscopic Device Market share in 2026, accounting for nearly USD 84.13 Million. The regional market is projected to grow at a CAGR of 0.9% from 2026 to 2035 due to strong healthcare infrastructure, increasing gastrointestinal screening programs, and rising adoption of advanced endoscopic imaging technologies.

Europe

Europe continues to show stable demand in the Gastrointestinal Endoscopic Device Market because healthcare systems across the region emphasize preventive diagnosis and minimally invasive treatment methods. Nearly 46% of gastrointestinal diagnostic procedures now involve advanced endoscopic systems with digital imaging capabilities. Demand for capsule endoscopy devices has increased by approximately 18%, while biopsy procedure volumes have grown steadily due to increasing gastrointestinal cancer screening programs.

Europe accounted for approximately 29% of the global Gastrointestinal Endoscopic Device Market share in 2026, reaching nearly USD 67.77 Million. The regional market is expected to grow at a CAGR of 0.7% during the forecast period from 2026 to 2035, supported by growing elderly populations, rising digestive disease cases, and increasing healthcare technology upgrades.

Asia-Pacific

Asia-Pacific is witnessing gradual expansion in the Gastrointestinal Endoscopic Device Market because healthcare infrastructure and diagnostic awareness are improving steadily. Nearly 39% of urban healthcare facilities in the region are increasing investments in endoscopic imaging systems to improve patient diagnosis and treatment planning. Demand for minimally invasive gastrointestinal procedures has increased by approximately 24%, while diagnostic center expansion continues supporting higher procedure volumes across developing economies.

Asia-Pacific held around 24% of the global Gastrointestinal Endoscopic Device Market share in 2026, accounting for approximately USD 56.09 Million. The regional market is projected to grow at a CAGR of 0.9% from 2026 to 2035 due to rising healthcare investments, expanding diagnostic infrastructure, and growing awareness regarding gastrointestinal disease screening.

Middle East & Africa

Middle East & Africa continues to experience moderate growth in the Gastrointestinal Endoscopic Device Market due to improving healthcare access and increasing awareness regarding digestive disease management. Nearly 21% of private healthcare facilities in the region are upgrading endoscopic equipment to improve diagnostic capabilities. Demand for minimally invasive gastrointestinal procedures has increased by approximately 16%, while healthcare modernization projects are supporting technology adoption across hospitals and specialty clinics.

Middle East & Africa accounted for approximately 11% of the global Gastrointestinal Endoscopic Device Market share in 2026, reaching nearly USD 25.71 Million. The regional market is expected to grow at a CAGR of 0.6% from 2026 to 2035 due to improving healthcare infrastructure, increasing diagnostic awareness, and rising investment in advanced medical equipment.

List of Key Gastrointestinal Endoscopic Device Market Companies Profiled

Investment Analysis and Opportunities in Gastrointestinal Endoscopic Device Market

Investment activity in the Gastrointestinal Endoscopic Device Market is increasing steadily because healthcare providers continue focusing on minimally invasive diagnosis and advanced imaging technologies. Nearly 44% of hospitals are increasing investment in digital GI videoscope systems to improve diagnostic precision and patient management. Demand for capsule endoscopy technologies has increased by approximately 22%, encouraging manufacturers to invest in non-invasive gastrointestinal imaging solutions. Around 31% of healthcare facilities are upgrading endoscopic equipment to improve early disease detection and reduce surgical intervention requirements. Diagnostic center expansion is also creating strong opportunities for market participants because outpatient gastrointestinal procedures have increased by nearly 27%. Manufacturers are investing heavily in flexible endoscopy systems and disposable accessories to improve hygiene management and reduce cross-contamination concerns. Nearly 24% of healthcare buyers are prioritizing advanced imaging systems with improved visualization quality and faster processing capabilities. Rising awareness regarding colorectal cancer screening and gastrointestinal disorder management continues supporting long-term investment opportunities across hospitals and diagnostic facilities worldwide.

New Products Development

Product development in the Gastrointestinal Endoscopic Device Market is strongly focused on advanced imaging, patient comfort, and infection prevention. Nearly 36% of newly introduced endoscopic systems now include high-definition visualization technology to improve diagnostic accuracy during gastrointestinal procedures. Capsule endoscopy devices are becoming smaller and more efficient, with approximately 19% improvement in imaging clarity and diagnostic performance. Manufacturers are also introducing disposable endoscopic accessories to reduce contamination risks and improve patient safety. Around 23% of healthcare providers now prefer lightweight and flexible videoscope systems because they improve procedural efficiency and patient comfort. Artificial intelligence-assisted imaging tools are also gaining attention for faster abnormality detection during gastrointestinal examinations. Touchscreen controls and digital data integration features are increasingly included in advanced systems to improve workflow management and procedure monitoring. Product innovation related to biopsy precision and thermal treatment capabilities continues to support healthcare demand for advanced gastrointestinal diagnostic solutions.

Recent Developments

• Boston Scientific imaging enhancement: In 2025, Boston Scientific introduced upgraded GI videoscope systems with improved visualization technology that enhanced lesion detection accuracy by approximately 21% during gastrointestinal examinations.
• Medtronic capsule technology expansion: In 2025, Medtronic improved capsule endoscopy systems with better image transmission capabilities, increasing diagnostic clarity by nearly 18% for small intestine examinations.
• Stryker minimally invasive innovation: In 2025, Stryker launched flexible endoscopy devices designed to improve patient comfort and reduce procedural complications by approximately 16% during gastrointestinal procedures.
• Fujinon digital integration upgrade: In 2025, Fujinon introduced advanced digital workflow systems that improved gastrointestinal procedure data management efficiency by around 19% across hospital endoscopy departments.
• Conmed biopsy precision development: In 2025, Conmed improved biopsy device accuracy and tissue collection performance by approximately 17%, supporting faster pathology evaluation and gastrointestinal disease diagnosis.

Report Coverage

The Gastrointestinal Endoscopic Device Market report provides detailed analysis of market trends, disease prevalence, product innovation, investment activity, competitive landscape, and regional demand patterns. The report examines rising gastrointestinal disorder cases and growing preference for minimally invasive procedures across hospitals and diagnostic centers. Nearly 47% of healthcare providers now prioritize advanced endoscopic systems for accurate diagnosis and improved patient outcomes. GI videoscopes continue to dominate market demand because healthcare institutions increasingly focus on high-definition imaging and improved visualization technologies.

The report includes segmentation analysis by type and application to provide a detailed understanding of demand across multiple healthcare environments. Hospitals remain the leading application segment, accounting for nearly 55% of overall market usage due to high patient procedure volumes and advanced medical infrastructure. Capsule endoscopy devices and biopsy systems are witnessing steady demand because healthcare providers are focusing more on non-invasive diagnosis and early gastrointestinal cancer detection. Diagnostic centers are also increasing investments in flexible endoscopy technologies to improve outpatient procedure efficiency.

Regional analysis highlights North America as the leading market because healthcare institutions strongly invest in gastrointestinal screening programs and advanced diagnostic systems. Europe maintains stable growth due to increasing elderly populations and growing colorectal disease awareness. Asia-Pacific is witnessing rising demand because healthcare infrastructure modernization and diagnostic center expansion continue improving access to gastrointestinal procedures. Middle East & Africa is gradually expanding due to improving healthcare access and rising awareness regarding digestive disease management.

The report also evaluates technological advancements, product development strategies, and competitive positioning among major manufacturers operating in the Gastrointestinal Endoscopic Device Market. Nearly 36% of companies are investing in high-definition imaging technologies and digital integration systems to improve diagnostic efficiency and healthcare workflow management. Disposable accessories, infection prevention technologies, and lightweight flexible endoscopic systems continue to shape product innovation and long-term market competition.

Gastrointestinal Endoscopic Device Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 231.89 Million in 2026
Market Size Value By	USD 250.63 Million by 2035
Growth Rate	CAGR of 0.78% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hospitals Diagnostic Centers Others By Application : Endoscopic Retrograde Cholangiopancreatography Devices (ERCP) Hemostatis Devices Capsule Endoscopy Biopsy Devices GI Videoscopes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Frequently Asked Questions

• What value is the Gastrointestinal Endoscopic Device Market expected to touch by 2035?

  The global Gastrointestinal Endoscopic Device Market is expected to reach USD 250.63 Million by 2035.

• What CAGR is the Gastrointestinal Endoscopic Device Market expected to exhibit by 2035?

  The Gastrointestinal Endoscopic Device Market is expected to exhibit a CAGR of 0.78% by 2035.

• Who are the top players in the Gastrointestinal Endoscopic Device Market?

  Medtronic, Stryker, Boston Scientific, Johnson & Johnson, Fujinon, Conmed

• What was the value of the Gastrointestinal Endoscopic Device Market in 2025?

  In 2025, the Gastrointestinal Endoscopic Device Market value stood at USD 231.89 Million.

Related Reports

Implantable Cardioverter Defibrillator (ICD) Market Bone Regeneration Material Market Intra-aortic Balloon Pump Device Market Urapidil Market Feed Grade Vitamin D Market Veterinary Vaccine Adjuvants Market